BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26516853)

  • 21. Evaluation of photodynamic therapy of skin cancers with partial differential alpha-aminolevulinic acid.
    Xu S; Wang X; Xu W; Xia Y; Zhang C
    Chin Med J (Engl); 2002 Aug; 115(8):1141-5. PubMed ID: 12215278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
    Szeimies RM
    Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy for non-melanoma skin cancer.
    Szeimies RM; Morton CA; Sidoroff A; Braathen LR
    Acta Derm Venereol; 2005; 85(6):483-90. PubMed ID: 16396794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic Therapy for Non-Melanoma Skin Cancers.
    Cohen DK; Lee PK
    Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27782043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma.
    Caekelbergh K; Annemans L; Lambert J; Roelandts R
    Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Photodynamic therapy in dermatooncology].
    Gaál M; Gyulai R; Baltás E; Kui R; Oláh J; Kemény L
    Orv Hetil; 2007 Nov; 148(47):2227-33. PubMed ID: 18003581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daylight Photodynamic Therapy: What is Known and What is Yet to be Determined.
    Fitzmaurice S; Eisen DB
    Dermatol Surg; 2016 Mar; 42(3):286-95. PubMed ID: 26918967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal cell carcinoma: an evidence-based treatment update.
    Clark CM; Furniss M; Mackay-Wiggan JM
    Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
    Boiy A; Roelandts R; de Witte PA
    J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of photodynamic therapy in dermatology: results of a consensus conference.
    Nestor MS; Gold MH; Kauvar AN; Taub AF; Geronemus RG; Ritvo EC; Goldman MP; Gilbert DJ; Richey DF; Alster TS; Anderson RR; Bank DE; Carruthers A; Carruthers J; Goldberg DJ; Hanke CW; Lowe NJ; Pariser DM; Rigel DS; Robins P; Spencer JM; Zelickson BD
    J Drugs Dermatol; 2006 Feb; 5(2):140-54. PubMed ID: 16485882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daylight-Photodynamic Therapy for the Treatment of Actinic Keratosis in Different Seasons.
    Cantisani C; Paolino G; Bottoni U; Calvieri S
    J Drugs Dermatol; 2015 Nov; 14(11):1349-53. PubMed ID: 26580886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Surgical Therapeutic Strategies for Non-Melanoma Skin Cancers.
    Zeng Q; Chen C; Chen D; Zhang G; Wang X
    Curr Treat Options Oncol; 2023 Dec; 24(12):1978-1993. PubMed ID: 38095778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy in treatment of cutaneous and choroidal melanoma.
    Kawczyk-Krupka A; Bugaj AM; Latos W; Zaremba K; Sieroń A
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):503-9. PubMed ID: 24284103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
    Ortiz-Policarpio B; Lui H
    Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAL-PDT for difficult to treat nonmelanoma skin cancer.
    Stebbins WG; Hanke CW
    Dermatol Ther; 2011; 24(1):82-93. PubMed ID: 21276161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging.
    Tierney E; Barker A; Ahdout J; Hanke CW; Moy RL; Kouba DJ
    Dermatol Surg; 2009 May; 35(5):725-46. PubMed ID: 19309338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of Photodynamic Therapy as a Possible Therapeutic Alternative in the Treatment of Basal Cell Carcinoma.
    Savoia P; Deboli T; Previgliano A; Broganelli P
    Int J Mol Sci; 2015 Sep; 16(10):23300-17. PubMed ID: 26426005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.